Ketamine Prevents Inflammation-Induced Reduction of Human Hippocampal Neurogenesis via Inhibiting the Production of Neurotoxic Metabolites of the Kynurenine Pathway. (2024)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1093/ijnp/pyae041
PubMed Identifier: 39297528
Publication URI: http://europepmc.org/abstract/MED/39297528
Type: Journal Article/Review
Volume: 27
Parent Publication: The international journal of neuropsychopharmacology
Issue: 10
ISSN: 1461-1457